Literature DB >> 31873839

Reduction of radiation and contrast agent exposure in a cryoballoon ablation procedure with integration of electromagnetic mapping and intracardiac echocardiography: a single center experience.

Joyce Maalouf1, Hoyle L Whiteside2, Ajay Pillai2, Abdullah Omar1, Adam Berman1, Samir Saba3, Haitham Hreibe4.   

Abstract

BACKGROUND: Pulmonary vein isolation (PVI) with cryoballoon ablation (CBA) is routinely guided by fluoroscopy and utilizes contrast injection to ensure catheter positioning and pulmonary vein occlusion. Non-fluoroscopic imaging techniques including electromagnetic mapping (EM) and intracardiac echocardiography (ICE) have demonstrated reduced fluoroscopy times and contrast exposure. Utilization of color flow Doppler to evaluate vein occlusion with the balloon has not been evaluated as an alternative to contrast injection. In this study we evaluate the effectiveness of cryoablation guided by EM and ICE along with color Doppler to achieve PVI.
METHODS: We designed a retrospective cohort study comparing patients who were treated before and after implementation of EM (Carto 3, Biosense Webster) and ICE during CBA (AF Solutions, Medtronic). We analyzed patients receiving CBA with fluoroscopy plus EM and ICE (group 2; N = 24) versus fluoroscopy alone (group 1; N = 25). Procedural success was defined as freedom from atrial fibrillation or other atrial arrhythmias at 1 year post ablation. Primary outcomes were radiation time and contrast exposure.
RESULTS: Procedural success was achieved in all cases. Total fluoroscopy time was reduced from 22.4 ± 9.8 min to 8.9 ± 5.1 min (P < 0.001) in patients receiving CBA guided by EM and ICE. Furthermore, exposure to contrast media was significantly lower at 75.4 ± 24.1 ml and 16.5 ± 21.1 ml (P ≤ 0.001) in group 1 and group 2, respectively. Neither the number of required cryotherapy treatments nor procedure duration was negatively impacted by the implementation of non-fluoroscopic techniques. The 1-year success rate was identical between both groups at 72% and 79%. There was no difference in complication rates.
CONCLUSION: This single-center cohort study demonstrates that CBA guided by EM and ICE can markedly reduce radiation and contrast exposure with excellent rates of acute PVI. This technique may be particularly effective in patients sensitive to intravenous contrast exposure.

Entities:  

Keywords:  Cryoballoon ablation; Fluoroscopy; Pulmonary vein isolation; Radiation exposure

Year:  2019        PMID: 31873839     DOI: 10.1007/s10840-019-00667-z

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  4 in total

1.  Intra-procedural three-dimensional rotational angiography in cryoballoon ablation for atrial fibrillation.

Authors:  Vedran Velagic; Giacomo Mugnai; Domagoj Kardum; Ivan Prepolec; Vedran Pasara; Mislav Puljevic; Davor Puljevic; Ivo Planinc; Jure Samardzic; Maja Cikes; Davor Milicic
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-16       Impact factor: 2.357

2.  Comparison of Using Second-Generation Cryoballoon and Radiofrequency Catheter for Atrial Fibrillation Ablation in Patients With the Common Ostium of Inferior Pulmonary Veins.

Authors:  Jia-Hui Li; Hai-Yang Xie; Qi Sun; Xiao-Gang Guo; Yan-Qiao Chen; Zhong-Jing Cao; Jian Ma
Journal:  Front Cardiovasc Med       Date:  2022-01-11

3.  JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.

Authors:  Akihiko Nogami; Takashi Kurita; Kengo Kusano; Masahiko Goya; Morio Shoda; Hiroshi Tada; Shigeto Naito; Teiichi Yamane; Masaomi Kimura; Tsuyoshi Shiga; Kyoko Soejima; Takashi Noda; Hiro Yamasaki; Yoshifusa Aizawa; Tohru Ohe; Takeshi Kimura; Shun Kohsaka; Hideo Mitamura
Journal:  J Arrhythm       Date:  2022-01-07

4.  Placement of catheters without magnetic sensors in the coronary sinus without fluoroscopic guidance: Feasibility and safety evaluation.

Authors:  Tadashi Hoshiyama; Hitoshi Sumi; Shozo Kaneko; Yusei Kawahara; Miwa Ito; Hisanori Kanazawa; Seiji Takashio; Eiichiro Yamamoto; Kenichi Matsushita; Kenichi Tsujita
Journal:  J Arrhythm       Date:  2022-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.